This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors

Title Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors
Abstract

In a search for structurally new inhibitors of fructose-1,6-bisphosphatase (F16BPase), substituted 2,3-dihydro-1H-cyclopenta[b]quinoline derivatives were synthesized. It has been shown that the 2,3-dihydro-1H-cyclopenta[b]quinoline moiety may represent a suitable scaffold for the synthesis of potent F16BPase inhibitors endowed with significantly lower EGFR tyrosine kinase inhibitory activity.

Apa Reference Rosini, M., Mancini, F., Tarozzi, A., Colizzi, F., Andrisano, V., Bolognesi, M.L., Hrelia, P. & Melchiorre, C. (2006). Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors. Bioorganic & Medicinal Chemistry, 14(23), 7846-7853. 10.1016/j.bmc.2006.07.059
Doi 10.1016/j.bmc.2006.07.059
Publication Date Dec 2006
Publication Type Article
Researcher Francesco Colizzi
Ontology Genome Assembly, Drug Discovery and design
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home